Literature DB >> 12025814

Amino acids in a region of ataxin-1 outside of the polyglutamine tract influence the course of disease in SCA1 transgenic mice.

Pamela J Skinner1, Cynthia A Vierra-Green, Effat Emamian, Huda Y Zoghbi, Harry T Orr.   

Abstract

Spinocerebellar ataxia type 1 (SCA1) belongs to a family of polyglutamine induced neurodegenerative disorders. Transgenic mice that overexpress a mutant allele of the SCA1 gene develop a progressive ataxia and Purkinje cell pathology. In this report, the pathological importance of a segment of ataxin-1 previously shown to be important for protein-protein interactions was examined. While the absence of a 122 amino acid segment from the protein-protein interaction region of ataxin-1 did not effect the initiation of disease, its absence substantially suppressed the progression of disease in SCA1 transgenic mice. Thus, these data suggest that this region of ataxin-1 has a role in disease progression. Furthermore, these results provide evidence that ataxin-1-induced disease initiation and disease progression involve distinct molecular events.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12025814     DOI: 10.1385/NMM:1:1:33

Source DB:  PubMed          Journal:  Neuromolecular Med        ISSN: 1535-1084            Impact factor:   3.843


  21 in total

1.  Purkinje cell expression of a mutant allele of SCA1 in transgenic mice leads to disparate effects on motor behaviors, followed by a progressive cerebellar dysfunction and histological alterations.

Authors:  H B Clark; E N Burright; W S Yunis; S Larson; C Wilcox; B Hartman; A Matilla; H Y Zoghbi; H T Orr
Journal:  J Neurosci       Date:  1997-10-01       Impact factor: 6.167

Review 2.  Glutamine repeats and neurodegeneration.

Authors:  H Y Zoghbi; H T Orr
Journal:  Annu Rev Neurosci       Date:  2000       Impact factor: 12.449

3.  Identification and characterization of an ataxin-1-interacting protein: A1Up, a ubiquitin-like nuclear protein.

Authors:  J D Davidson; B Riley; E N Burright; L A Duvick; H Y Zoghbi; H T Orr
Journal:  Hum Mol Genet       Date:  2000-09-22       Impact factor: 6.150

4.  A huntingtin-associated protein enriched in brain with implications for pathology.

Authors:  X J Li; S H Li; A H Sharp; F C Nucifora; G Schilling; A Lanahan; P Worley; S H Snyder; C A Ross
Journal:  Nature       Date:  1995-11-23       Impact factor: 49.962

5.  Expression analysis of the ataxin-1 protein in tissues from normal and spinocerebellar ataxia type 1 individuals.

Authors:  A Servadio; B Koshy; D Armstrong; B Antalffy; H T Orr; H Y Zoghbi
Journal:  Nat Genet       Date:  1995-05       Impact factor: 38.330

6.  Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1.

Authors:  C J Cummings; M A Mancini; B Antalffy; D B DeFranco; H T Orr; H Y Zoghbi
Journal:  Nat Genet       Date:  1998-06       Impact factor: 38.330

7.  Huntingtin interacts with a family of WW domain proteins.

Authors:  P W Faber; G T Barnes; J Srinidhi; J Chen; J F Gusella; M E MacDonald
Journal:  Hum Mol Genet       Date:  1998-09       Impact factor: 6.150

8.  SCA1 transgenic mice: a model for neurodegeneration caused by an expanded CAG trinucleotide repeat.

Authors:  E N Burright; H B Clark; A Servadio; T Matilla; R M Feddersen; W S Yunis; L A Duvick; H Y Zoghbi; H T Orr
Journal:  Cell       Date:  1995-09-22       Impact factor: 41.582

9.  Structural and immunocytochemical features of olivopontocerebellar atrophy caused by the spinocerebellar ataxia type 1 (SCA-1) mutation define a unique phenotype.

Authors:  Y Robitaille; L Schut; S J Kish
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

10.  Intracellular localization of proteasomal degradation of a viral antigen.

Authors:  L C Antón; U Schubert; I Bacík; M F Princiotta; P A Wearsch; J Gibbs; P M Day; C Realini; M C Rechsteiner; J R Bennink; J W Yewdell
Journal:  J Cell Biol       Date:  1999-07-12       Impact factor: 10.539

View more
  5 in total

1.  Nuclear aggregation of polyglutamine-expanded ataxin-3: fragments escape the cytoplasmic quality control.

Authors:  Peter Breuer; Annette Haacke; Bernd O Evert; Ullrich Wüllner
Journal:  J Biol Chem       Date:  2010-01-11       Impact factor: 5.157

2.  Comparison of Vibratome and Compresstome sectioning of fresh primate lymphoid and genital tissues for in situ MHC-tetramer and immunofluorescence staining.

Authors:  Hadia M Abdelaal; Hyeon O Kim; Reece Wagstaff; Ryoko Sawahata; Peter J Southern; Pamela J Skinner
Journal:  Biol Proced Online       Date:  2015-01-07       Impact factor: 3.244

Review 3.  Kaleidoscopic protein-protein interactions in the life and death of ataxin-1: new strategies against protein aggregation.

Authors:  Cesira de Chiara; Annalisa Pastore
Journal:  Trends Neurosci       Date:  2014-03-11       Impact factor: 13.837

Review 4.  Mouse models of polyglutamine diseases: review and data table. Part I.

Authors:  Maciej Figiel; Wojciech J Szlachcic; Pawel M Switonski; Agnieszka Gabka; Wlodzimierz J Krzyzosiak
Journal:  Mol Neurobiol       Date:  2012-09-07       Impact factor: 5.590

5.  Motor and Cerebellar Architectural Abnormalities during the Early Progression of Ataxia in a Mouse Model of SCA1 and How Early Prevention Leads to a Better Outcome Later in Life.

Authors:  Mohamed F Ibrahim; Emmet M Power; Kay Potapov; Ruth M Empson
Journal:  Front Cell Neurosci       Date:  2017-09-20       Impact factor: 5.505

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.